Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(13):1238-1251.
doi: 10.2174/0113895575281039231218112953.

Quinoline Derivatives as Promising Scaffolds for Antitubercular Activity: A Comprehensive Review

Affiliations
Review

Quinoline Derivatives as Promising Scaffolds for Antitubercular Activity: A Comprehensive Review

Mohammad Owais et al. Mini Rev Med Chem. 2024.

Abstract

Background: Heterocyclic compounds and their derivatives play a significant role in the design and development of novel quinoline drugs. Among the various pharmacologically active heterocyclic compounds, quinolines stand out as the most significant rings due to their broad pharmacological roles, specifically antitubercular activity, and their presence in plant-based compounds. Quinoline is also known as benzpyridine, benzopyridine, and 1-azanaphthalene. It has a benzene ring fused with a pyridine ring, and both rings share two carbon atoms. The importance of quinoline lies in its incorporation as a key component in various natural compounds found in medicinal plant families like Fumariaceae, Berberidaceae, Rutaceae, Papavaraceae, and others.

Objective: This article is expected to have a significant impact on the advancement of effective antitubercular drugs. Through harnessing the potent activity of quinoline derivatives, the research aims to make valuable contributions to combating tuberculosis more efficiently and ultimately reducing the global burden of this infectious disease.

Methods: Numerous nitrogen-containing heterocyclic compounds exhibit significant potential as antitubercular agents. These chemicals have fused aromatic nitrogen-heterocyclic nuclei that can change the number of electrons they have, which can change their chemical, physical, and biological properties. This versatility comes from their ability to bind with the receptors in multiple modes, a critical aspect of drug pharmacological screening. Among these compounds, quinoline stands out as it incorporates a stable fusion of a benzene ring with a pyridine nucleus. Quinolines have demonstrated a diverse range of pharmacological activities, including but not limited to anti-tubercular, anti-tumor, anticoagulant, anti-inflammatory, antioxidant, antiviral, antimalarial, anti-HIV, and antimicrobial effects.

Results: Some molecules, such as lone-paired nitrogen species, include pyrrole, pyrazole, and quinoline. These molecules contain nitrogen and take part in metabolic reactions with other molecules inside the cell. However, an excessive accumulation of reactive nitrogen species can lead to cytotoxicity, resulting in damage to essential biological macromolecules. Among these compounds, quinoline stands out as the oldest and most effective one, exhibiting a wide range of significant properties such as antitubercular, antimicrobial, anti-inflammatory, antioxidant, analgesic, and anticonvulsant activities. Notably, naturally occurring quinoline compounds, such as quinine, have proven to be potent antimalarial drugs.

Conclusion: This review highlights quinoline derivatives' antitubercular potential, emphasizing recent research advancements. Utilizing IC50 values, the study emphasizes the efficacy of various quinoline substitutions, hybrids, and electron-withdrawing groups against MTB H37Rv. Continued research is essential for developing potent, low-toxicity quinoline derivatives to combat tuberculosis.

Keywords: HIV; Tuberculosis; heterocyclic compounds; isoniazid.; mycobacterium tuberculosis; quinoline.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brooks J.T.; Kaplan J.E.; Holmes K.K.; Benson C.; Pau A.; Masur H.; HIV-associated opportunistic infections--going, going, but not gone: The continued need for prevention and treatment guidelines. Clin Infect Dis 2009,48(5),609-611 - DOI - PubMed
    1. Global tuberculosis report World Health Organization (WHO) Available from: https://www.who.int/teams/global-tuberculosis-programme/data
    1. Engohang-Ndong J.; Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment. Expert Opin Investig Drugs 2012,21(12),1789-1800 - DOI - PubMed
    1. Solomon V.R.; Lee H.; Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem 2011,18(10),1488-1508 - DOI - PubMed
    1. Manske R.H.; The chemistry of quinolines. Chem Rev 1942,30(1),113-144 - DOI

LinkOut - more resources